Henry Schein (HSIC, Health Care Distributors) Stock Valuation & Fair Value Fairly valued
Henry Schein (HSIC, Health Care Distributors) trades at a blended P/E of 16.9, about 12% below its historical normal valuation, with a forward growth estimate of 9.8% and a PEG of 1.74. Analysts' one-year estimates have been hit 64% of the time.
Valuation flags
- No notable valuation flags.
Verdict history
tickerseer's rating has been fairly valued since 2026-06-03.
Not every point was recorded live. Points marked recalculated apply today's valuation rules to the metrics tickerseer archived that week.
Frequently asked questions
Is Henry Schein stock overvalued?
At a blended P/E of 16.9 versus its historical normal P/E of 19.2, Henry Schein trades about 12% below its typical valuation, with a PEG of 1.74 on 9.8% forward growth. tickerseer currently rates it fairly valued.
What is Henry Schein's fair value and PEG?
Henry Schein trades at a blended P/E of 16.9 against a historical normal P/E of 19.2, a PEG of 1.74, and a forward growth estimate of 9.8%.
Has tickerseer's rating of Henry Schein changed?
tickerseer's rating has been fairly valued since 2026-06-03.
Industry: Health Care Distributors. Create a free account to see the full analysis: the SeerAI score, its five quality sub-scores, valuation history, and the AI research note. Options setups and metric history are part of the paid plans.
Get the free weekly earnings preview
One email each Monday with the week's named earnings setups, the reasoning, and what settled last week. Strikes and sizing stay in Premium.
It's free, and you can unsubscribe any time. Educational content, not investment advice.